IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
39 hedge funds and large institutions have $73.9M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$539K | |
| 2 | +$163K | |
| 3 | +$149K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$64K |
| 5 |
BlackRock
New York
|
+$47.7K |
Top Sellers
| 1 | -$547K | |
| 2 | -$48.8K | |
| 3 | -$19.8K | |
| 4 |
E
Ergoteles
New York
|
-$19.2K |
| 5 |
Goldman Sachs
New York
|
-$15K |